系统综述与Meta分析:炎症性肠病中小肠细菌过度生长的患病率
该系统综述与Meta分析检索至2018年5月的电子数据库,纳入11项研究(1175例成人IBD患者和407例对照),均采用呼气试验诊断SIBO。IBD患者SIBO合并患病率为22.3%(95%CI 19.92-24.68),IBD患者SIBO的OR为9.51(95%CI 3.39-26.68),CD和UC中均高。
要点
- IBD患者SIBO合并患病率为22.3%(95%CI 19.92-24.68)。
- IBD患者SIBO的OR为9.51(95%CI 3.39-26.68),高于非IBD对照。
- CD中纤维狭窄性疾病和既往肠道手术增加SIBO风险。
核心结论
- 总体上,IBD患者SIBO患病率较对照大幅增加,既往手术和纤维狭窄性疾病是IBD患者SIBO的危险因素。
研究设计与样本
- 系统综述与Meta分析,检索电子数据库至2018年5月,纳入11项报告IBD患者SIBO患病率的研究(1175例成人IBD患者和407例对照),均采用呼气试验诊断SIBO。
主要发现
- IBD患者SIBO比例为22.3%(95%CI 19.92-24.68)。
- IBD患者SIBO的OR为9.51(95%CI 3.39-26.68),高于非IBD对照。
- CD患者SIBO的OR为10.86(95%CI 2.76-42.69),UC患者SIBO的OR为7.96(95%CI 1.66-38.35)。
- CD患者亚组分析显示,纤维狭窄性疾病(OR=7.47;95%CI 2.51-22.20)和既往肠道手术(OR=2.38;95%CI 1.65-3.44),尤其是回盲瓣切除,增加SIBO的 odds。
- 个别研究提示合并小肠和大肠疾病但与疾病活动度无关可能与小肠细菌过度生长相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current data on small intestinal bacterial overgrowth (SIBO) in patients with inflammatory bowel diseases (IBD) are controversial. AIM: To conduct a systematic review and meta-analysis to determine the prevalence of SIBO in patients with ulcerative colitis (UC) and Crohn's disease (CD). METHODS: Electronic databases were searched up to May 2018 for studies reporting prevalence of SIBO in IBD patients. The prevalence rate of SIBO among IBD patients and the odds ratio (OR) and 95% CI of SIBO in IBD patients compared with controls were calculated. RESULTS: The final dataset included 11 studies (1175 adult patients with IBD and 407 controls), all utilising breath test for diagnosis of SIBO. The proportion of SIBO in IBD patients was 22.3% (95% CI 19.92-24.68). The OR for SIBO in IBD patients was 9.51 (95% CI 3.39-26.68) compared to non-IBD controls, and high in both CD (OR = 10.86; 95% CI 2.76-42.69) and UC (OR = 7.96; 95% CI 1.66-38.35). In patients with CD, subgroup analysis showed the presence of fibrostenosing disease (OR = 7.47; 95% CI 2.51-22.20) and prior bowel surgery (OR = 2.38; 95% CI 1.65-3.44), especially resection of the ileocecal valve, increased the odds of SIBO. Individual studies suggest that combined small and large bowel disease but not disease activity may be associated with SIBO. CONCLUSIONS: Overall, there is a substantial increase in the prevalence of SIBO in IBD patients compared to controls. Prior surgery and the presence of fibrostenosing disease are risk factors for SIBO in IBD.
引用
- Shah A, Morrison M, Burger D, et al. Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Aliment Pharmacol Ther. 2019. PMID: 30735254. doi:10.1111/apt.15133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。